BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21228930)

  • 1. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
    Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
    Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
    Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
    Liang SX; Chambers SK; Cheng L; Zhang S; Zhou Y; Zheng W
    Int J Surg Pathol; 2004 Oct; 12(4):319-31. PubMed ID: 15494858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
    Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
    Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
    Sherman ME; Bur ME; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia.
    Yi X; Zheng W
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):20-5. PubMed ID: 18197001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
    Lu B; Chen Q; Zhang X; Cheng L
    Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.
    Zhang X; Liang SX; Jia L; Chen N; Fadare O; Schwartz PE; Kong B; Zheng W
    Am J Pathol; 2009 Jun; 174(6):2000-6. PubMed ID: 19435786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal p16 expression is significantly increased in endometrial carcinoma.
    Yoon G; Koh CW; Yoon N; Kim JY; Kim HS
    Oncotarget; 2017 Jan; 8(3):4826-4836. PubMed ID: 27902476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial intraepithelial carcinoma: a case report and brief review.
    Ram M; Bharadwaj M; Yadav R
    Indian J Pathol Microbiol; 2008; 51(4):512-4. PubMed ID: 19008579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.
    Abushahin N; Zhang T; Chiang S; Zhang X; Hatch K; Zheng W
    Int J Gynecol Pathol; 2011 May; 30(3):271-81. PubMed ID: 21464726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
    Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
    Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.
    Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP
    Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical profile of atypical eosinophilic syncytial changes vs serous carcinoma.
    Haley SL; Malhotra RK; Qiu S; Eltorky ME
    Ann Diagn Pathol; 2011 Dec; 15(6):402-6. PubMed ID: 21855381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
    Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of p53 expression in background endometrium in endometrial carcinoma.
    Nguyen TT; Hachisuga T; Urabe R; Kurita T; Kagami S; Kawagoe T; Shimajiri S; Nabeshima K
    Virchows Arch; 2015 Jun; 466(6):695-702. PubMed ID: 25788166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
    Egan JA; Ionescu MC; Eapen E; Jones JG; Marshall DS
    Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.